Aura Biosciences, Inc.
AURA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $363,178 | $293,739 | $408,127 |
| - Cash | $47,553 | $107,367 | $38,226 | $31,693 |
| + Debt | $14,534 | $18,112 | $18,444 | $18,769 |
| Enterprise Value | – | $273,923 | $273,957 | $395,203 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$300 | -$300 | $0 | -$291 |
| % Margin | – | – | – | – |
| EBITDA | -$25,804 | -$26,671 | -$28,744 | -$25,519 |
| % Margin | – | – | – | – |
| Net Income | -$26,130 | -$27,019 | -$27,483 | -$25,834 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.4 | -0.47 | -0.55 | -0.52 |
| % Growth | 14.9% | 14.5% | -5.8% | – |
| Operating Cash Flow | -$20,144 | -$20,774 | -$23,355 | -$23,952 |
| Capital Expenditures | -$45 | -$39 | -$187 | -$299 |
| Free Cash Flow | -$20,189 | -$20,813 | -$23,542 | -$24,251 |